Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-94.44	33.56	603.77
Graham Fair Price	-3.78	37.53	39.00
PEG	-50.03	-1.09	2.18
Price/Book	1.45	1.40	1.38
Price/Cash Flow	0.66	26.56	26.39
Prices/Earnings	12.51	8.91	7.92
Price/Sales	3.99	13.65	13.12
Price/FCF	0.66	26.56	26.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-26.49	0.38	0.52
ROA	-9.72	< 0.005	< 0.005
ROE	0.04	0.04	-9.83
ROIC	0.03	0.02	-28.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	4.43	-98.11
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.30	-0.27	-7.76
EPS QOQ	0.04	-0.08	125.15
FCF QOQ	0.22	0.02	-89.79
Revenue QOQ	0.21	-0.01	-95.17
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	22.88	23.47	2.62
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.21	0.22	5.30
Quick Ratio	0.70	1.03	46.44
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	39.44	39.97	1.33
Cash	88.19	91.37	3.60
Capex	-0.14	-0.11	22.41
Free Cash Flow	2.06	2.10	2.12
Revenue	4.14	4.09	-1.14
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.09	0.18	85.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.18	-2.10	-1039.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating